- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01756235
Physical Activity in Patients With Rheumatoid Arthritis Treated With Adalimumab in Routine Clinical Practice (PACE)
January 17, 2017 updated by: AbbVie (prior sponsor, Abbott)
Physical ACtivity in patiEnts With Rheumatoid Arthritis Treated With Adalimumab in Routine Clinical Practice (PACE)
The purpose of this study was to evaluate physical activity and its changes in participants with rheumatoid arthritis (RA) who were treated with adalimumab therapy in clinical practice.
Study Overview
Status
Completed
Conditions
Detailed Description
This post-marketing observational study was conducted in a multi-country, multi-center and single-arm format.
Data were collected prospectively.
Adult participants with diagnosis of RA who were assigned for treatment with adalimumab (Humira®) were eligible for participation.
During this period four follow-up visits were planned for observation of the participant and documentation of data.
Ideally, these visits should have been performed approximately 3 (V1), 6 (V2), 9 (V3) and 12 (V4) months after the baseline visit (V0).
Study Type
Observational
Enrollment (Actual)
462
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Study population consisted of participants with rheumatoid arthritis (RA) who were treated with adalimumab as per locally approved label and prescription guidelines.
The decision to be treated with adalimumab had to be independent from study inclusion.
Description
Inclusion Criteria:
- Had rheumatoid arthritis (RA) and is eligible to start and/or continue adalimumab therapy according to the local product label and prescription guidelines
- Had been started on adalimumab therapy no more than one (1) month prior to the study enrolment
- Had negative result of tuberculosis (TB) screening test or was receiving TB prophylaxis as per local guidelines
- Had provided written Authorization to the investigator to use and/or disclose personal and/or health data, or Informed Consent if requested by the Local Regulations
Exclusion Criteria:
- Was unable to walk either due to RA or a comorbid condition
- Was unable to perform basic self-care activities
- Had contraindications for treatment with adalimumab
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Participants with Rheumatoid Arthritis
Participants with rheumatoid arthritis treated with adalimumab in routine clinical practice.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Change From Baseline in Total Physical Activity Short Questionnaire to Assess Health-enhancing Physical Activity (SQUASH) Score
Time Frame: Month 0 (baseline) and Month 12 (Last Observation Carried Forward (LOCF))
|
The quantitative SQUASH score (scores range from 0 to 17010.000) is calculated as the sum of subscores that capture physical activity related to commuting activities (SQUASH-A), scores range from 0 to 4082.400, leisure time activities (SQUASH-B), scores range from 0 to 6123.600, household activities (SQUASH-C), scores range from 0 to 3402.000, and activity at work and school (SQUASH-D), scores range from 0 to 3402.000.
The SQUASH score and its subscores has non-negative values.
Higher values indicate a higher individual activity level.
|
Month 0 (baseline) and Month 12 (Last Observation Carried Forward (LOCF))
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Change From Baseline in Total Physical Activity SQUASH Score
Time Frame: Month 3, Month 6 and Month 9
|
The quantitative SQUASH score (scores range from 0 to 17010.000) is calculated as the sum of subscores that capture physical activity related to commuting activities (SQUASH-A), scores range from 0 to 4082.400, leisure time activities (SQUASH-B), scores range from 0 to 6123.600, household activities (SQUASH-C), scores range from 0 to 3402.000, and activity at work and school (SQUASH-D), scores range from 0 to 3402.000.
The SQUASH score and its subscores has non-negative values.
Higher values indicate a higher individual activity level.
|
Month 3, Month 6 and Month 9
|
Mean Change From Baseline in SQUASH-A Scores
Time Frame: Month 3, Month 6, Month 9, Month 12 and Month 12 LOCF
|
SQUASH subscores capture physical activity.
SQUASH-A subscore captures commuting activities, with scores ranging from 0 to 4082.400.
The SQUASH subscores have non-negative values.
Higher values indicate a higher individual activity level.
|
Month 3, Month 6, Month 9, Month 12 and Month 12 LOCF
|
Mean Change From Baseline in SQUASH-B Scores
Time Frame: Month 3, Month 6, Month 9, Month 12 and Month 12 LOCF
|
SQUASH subscores capture physical activity.
SQUASH-B subscore captures leisure time activities, with scores ranging from 0 to 6123.600.
The SQUASH subscores have non-negative values.
Higher values indicate a higher individual activity level.
|
Month 3, Month 6, Month 9, Month 12 and Month 12 LOCF
|
Mean Change From Baseline in SQUASH-C Scores
Time Frame: Month 3, Month 6, Month 9, Month 12 and Month 12 LOCF
|
SQUASH subscores capture physical activity.
SQUASH-C subscore captures house-hold activities, with scores ranging from 0 to 3402.000.
The SQUASH subscores have non-negative values.
Higher values indicate a higher individual activity level.
|
Month 3, Month 6, Month 9, Month 12 and Month 12 LOCF
|
Mean Change From Baseline in SQUASH-D Scores
Time Frame: Month 3, Month 6, Month 9, Month 12 and Month 12 LOCF
|
SQUASH subscores capture physical activity.
SQUASH-D subscore captures activity at work and school, with scores ranging from 0 to 3402.000.
The SQUASH subscores have non-negative values.
Higher values indicate a higher individual activity level.
|
Month 3, Month 6, Month 9, Month 12 and Month 12 LOCF
|
Mean Change From Baseline in Disease Activity Index - 28 Joints (DAS28) Score
Time Frame: Month 3, Month 6, Month 9, Month 12 and Month 12 LOCF
|
The DAS28 is a validated index of rheumatoid arthritis disease activity.
Tender joint counts and swollen joint counts across 28 joints, C-reactive protein, and general health assessed via the visual analog scale (VAS) are included in the DAS28 score.
Scores on the DAS28 range from 0 to 10.
A DAS28 score >5.1 indicates high disease activity, a DAS28 score <3.2 indicates low disease activity, and a DAS28 score <2.6 indicates clinical remission.
|
Month 3, Month 6, Month 9, Month 12 and Month 12 LOCF
|
Percentage of Participants in Clinical Disease Remission (DAS28<2.6)
Time Frame: Month 0, Month 3, Month 6, Month 9, Month 12 and Month 12 LOCF
|
Remission is defined as DAS28 of less than 2.6.
The DAS28 is a validated index of rheumatoid arthritis disease activity.
Tender joint counts and swollen joint counts across 28 joints, C-reactive protein (CRP), and general health assessed via the visual analog scale (VAS) are included in the DAS28 score.
Scores on the DAS28 range from 0 to 10, with higher scores indicating higher disease activity.
|
Month 0, Month 3, Month 6, Month 9, Month 12 and Month 12 LOCF
|
Percentage of Participants With Low Disease Activity State (LDAS, DAS28<3.2)
Time Frame: Month 0, Month 3, Month 6, Month 9, Month 12 and Month 12 LOCF
|
LDAS is defined as DAS28 of less than 3.2.
The DAS28 is a validated index of rheumatoid arthritis disease activity.
Tender joint counts and swollen joint counts across 28 joints, C-reactive protein (CRP), and general health assessed via the visual analog scale (VAS) are included in the DAS28 score.
Scores on the DAS28 range from 0 to 10, with higher scores indicating higher disease activity.
|
Month 0, Month 3, Month 6, Month 9, Month 12 and Month 12 LOCF
|
Mean Change From Baseline in Total Physical Activity SQUASH Scores and Individual Physical Activity Categories' SQUASH Scores in Participants in Remission or LDAS
Time Frame: Month 3, Month 6, Month 9, Month 12 and Month 12 LOCF
|
This outcome analyses the quantitative SQUASH score and individual SQUASH scores by DAS28 categories.
The quantitative SQUASH score (ranging from 0 to 17010.000) is calculated as the sum of subscores that capture physical activity related to commuting activities (SQUASH-A), leisure time activities (SQUASH-B), household activities (SQUASH-C) and activity at work and school (SQUASH-D).
The SQUASH score and its subscores has non-negative values.
Higher values indicate a higher individual activity level.
DAS28 categories being assessed are remission (defined as DAS28 of less than 2.6) and LDAS (defined as DAS28 of less than 3.2).The DAS28 is a validated index of rheumatoid arthritis disease activity.
Tender joint counts and swollen joint counts across 28 joints, C-reactive protein (CRP), and general health assessed via the visual analog scale (VAS) are included in the DAS28 score.
Scores on the DAS28 range from 0 to 10, with higher scores indicating higher disease activity.
|
Month 3, Month 6, Month 9, Month 12 and Month 12 LOCF
|
Mean Change From Baseline in Total Physical Activity SQUASH Scores and Individual Physical Activity Categories' SQUASH Scores in Participants Those Who Did Not Attain Remission or LDAS
Time Frame: Month 3, Month 6, Month 9, Month 12 and Month 12 LOCF
|
This outcome analyses the quantitative SQUASH score and individual SQUASH scores by DAS28 categories.
The quantitative SQUASH score (ranging from 0 to 17010.000) is calculated as the sum of subscores that capture physical activity related to commuting activities (SQUASH-A), leisure time activities (SQUASH-B), household activities (SQUASH-C) and activity at work and school (SQUASH-D).
The SQUASH score and its subscores has non-negative values.
Higher values indicate a higher individual activity level.
DAS28 categories being assessed are remission (defined as DAS28 of less than 2.6) and LDAS (defined as DAS28 of less than 3.2).The DAS28 is a validated index of rheumatoid arthritis disease activity.
Tender joint counts and swollen joint counts across 28 joints, C-reactive protein (CRP), and general health assessed via the visual analog scale (VAS) are included in the DAS28 score.
Scores on the DAS28 range from 0 to 10, with higher scores indicating higher disease activity.
|
Month 3, Month 6, Month 9, Month 12 and Month 12 LOCF
|
Mean Change From Baseline in Health Assessment Questionnaire Disability Index (HAQ-DI) Score
Time Frame: Month 3, Month 6, Month 9, Month 12 and Month 12 LOCF
|
The Health Assessment Questionnaire - Disability Index (HAQ-DI) is a patient-reported questionnaire specific for rheumatoid arthritis.
It consists of 20 questions referring to eight domains: dressing/grooming, arising, eating, walking, hygiene, reach, grip, and daily activities.
Participants assessed their ability to do each task over the past week using the following response categories: without any difficulty (0); with some difficulty (1); with much difficulty (2); and unable to do (3).
Scores range from 0 to 3, where zero represents no disability and three very severe, high-dependency disability.
Scores on each task were summed and averaged to provide an overall score ranging from 0 to 3, where zero represents no disability and three very severe, high-dependency disability.
Negative mean changes from baseline in the overall score indicates improvement.
|
Month 3, Month 6, Month 9, Month 12 and Month 12 LOCF
|
Correlation Between Physical Activity (Total SQUASH Score and Individual Physical Activity Categories' SQUASH Scores) and DAS28 Scores
Time Frame: Month 0 and Month 12 LOCF
|
The SQUASH and its subscores are instruments to measure the physical activity level, whereas the DAS28 measures disease activity.
In order to evaluate the relationship between physical function and disease activity (as measured by the two scales), Pearson correlation coefficients were calculated for the SQUASH scores and the DAS28.
A decrease in physical functioning is likely to be connected to stronger disease activity.
|
Month 0 and Month 12 LOCF
|
Correlation Between Physical Activity (Total SQUASH Score and Individual Physical Activity Categories' SQUASH Scores) and HAQ-DI Scores
Time Frame: Month 0 and Month 12 LOCF
|
The SQUASH and its subscores are instruments to measure the physical activity level, whereas the HAQ-DI measures physical functioning.
In order to evaluate the relationship between physical function and physical activity (as measured by the both scales), Pearson correlation coefficients were calculated for the SQUASH scores and the HAQ-DI.
A decrease in physical functioning is likely to prohibit physical activity.
|
Month 0 and Month 12 LOCF
|
Mean Change From Baseline in Physical Activity (Total SQUASH Score and Individual Physical Activity Categories' SQUASH Scores) Influenced by Age Categories
Time Frame: Month 0 and Month 12 LOCF
|
The quantitative SQUASH score (scores range from 0 to 17010.000) is calculated as the sum of subscores that capture physical activity related to commuting activities (SQUASH-A), scores range from 0 to 4082.400, leisure time activities (SQUASH-B), scores range from 0 to 6123.600, household activities (SQUASH-C), scores range from 0 to 3402.000, and activity at work and school (SQUASH-D), scores range from 0 to 3402.000.
The SQUASH score and its subscores has non-negative values.
Higher values indicate a higher individual activity level.
|
Month 0 and Month 12 LOCF
|
Mean Change From Baseline in Physical Activity (Total SQUASH Score and Individual Physical Activity Categories' SQUASH Scores) Influenced by Gender
Time Frame: Month 0 and Month 12 LOCF
|
The quantitative SQUASH score (scores range from 0 to 17010.000) is calculated as the sum of subscores that capture physical activity related to commuting activities (SQUASH-A), scores range from 0 to 4082.400, leisure time activities (SQUASH-B), scores range from 0 to 6123.600, household activities (SQUASH-C), scores range from 0 to 3402.000, and activity at work and school (SQUASH-D), scores range from 0 to 3402.000.
The SQUASH score and its subscores has non-negative values.
Higher values indicate a higher individual activity level.
|
Month 0 and Month 12 LOCF
|
Mean Change From Baseline in Physical Activity (Total SQUASH Score and Individual Physical Activity Categories' SQUASH Scores) Influenced by Education
Time Frame: Month 0 and Month 12 LOCF
|
The quantitative SQUASH score (scores range from 0 to 17010.000) is calculated as the sum of subscores that capture physical activity related to commuting activities (SQUASH-A), scores range from 0 to 4082.400, leisure time activities (SQUASH-B), scores range from 0 to 6123.600, household activities (SQUASH-C), scores range from 0 to 3402.000, and activity at work and school (SQUASH-D), scores range from 0 to 3402.000.
The SQUASH score and its subscores has non-negative values.
Higher values indicate a higher individual activity level.
|
Month 0 and Month 12 LOCF
|
Mean Change From Baseline in Physical Activity (Total SQUASH Score and Individual Physical Activity Categories' SQUASH Scores) Influenced by Occupation
Time Frame: Month 0 and Month 12 LOCF
|
The quantitative SQUASH score (scores range from 0 to 17010.000) is calculated as the sum of subscores that capture physical activity related to commuting activities (SQUASH-A), scores range from 0 to 4082.400, leisure time activities (SQUASH-B), scores range from 0 to 6123.600, household activities (SQUASH-C), scores range from 0 to 3402.000, and activity at work and school (SQUASH-D), scores range from 0 to 3402.000.
The SQUASH score and its subscores has non-negative values.
Higher values indicate a higher individual activity level.
|
Month 0 and Month 12 LOCF
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Elena Smirnova, MD, AbbVie
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2012
Primary Completion (Actual)
October 1, 2015
Study Completion (Actual)
October 1, 2015
Study Registration Dates
First Submitted
December 20, 2012
First Submitted That Met QC Criteria
December 20, 2012
First Posted (Estimate)
December 25, 2012
Study Record Updates
Last Update Posted (Actual)
March 6, 2017
Last Update Submitted That Met QC Criteria
January 17, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P13-683
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rheumatoid Arthritis
-
Janssen Research & Development, LLCWithdrawnActive Rheumatoid Arthritis; Rheumatoid Arthritis
-
Centocor, Inc.CompletedRheumatoid Arthritis, Juvenile
-
AmgenTerminated
-
Children's Hospital Medical Center, CincinnatiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedJuvenile Rheumatoid ArthritisUnited States
-
AmgenImmunex CorporationCompletedJuvenile Rheumatoid Arthritis
-
National Institute of Arthritis and Musculoskeletal...Children's Hospital Medical Center, CincinnatiCompleted
-
University of PittsburghNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedRheumatoid Arthritis | Juvenile Rheumatoid ArthritisUnited States
-
University of Missouri-ColumbiaCompletedJuvenile Rheumatoid ArthritisUnited States
-
Assistance Publique - Hôpitaux de ParisSociete Francaise de RhumatologieRecruiting
-
Amsterdam UMC, location VUmcEuropean CommissionCompletedRheumatoId ArthritisNetherlands, Germany, Portugal, Italy, Hungary, Romania, Slovakia